logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories – notice of Annual General Meeting on May 20, 2025

Annual General Meeting, Investor News 2025-04-16
Stockholm – April 16, 2025 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]
Read More

Panel talk about Inify’s fourth quarter 2024

Investor News 2025-02-28
Inify Laboratories continues to strengthen its position in the diagnostics market, achieving significant growth and expanding its reach. In Q4 2024, sales increased by 60% compared to the previous quarter […]
Read More

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Financial reports, Investor News 2025-02-26
STOCKHOLM – February 26, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, saw sales grow by 60% compared to the previous quarter, and 472% […]
Read More

Inify Laboratories – New share capital registered

Investor News 2025-02-14
Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 12 February 2025 regarding the resolution to issue 30,202,366 new shares in a private […]
Read More

Inify Laboratories – Resolution to issue new shares in Private Placement and Subsequent Offering

Investor News 2025-02-12
Reference is made to the stock exchange announcements made by Inify Laboratories AB (the "Company") on 16 December 2024 regarding the allocation of 30,202,366 new shares in a private placement […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-30
Stockholm, Sweden, January 30, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Olof Sandén, board member and […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-01-24
  Stockholm, Sweden, January 24, 2024; Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 23 January 2024, regarding the final results of […]
Read More

Inify Laboratories – Final results of the Subsequent Offering

Investor News 2025-01-23
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]
Read More

Inify Laboratories – Last day of the subscription period in the Subsequent Offering

Investor News 2025-01-23
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]
Read More

Inify Laboratories – Commencement of subscription period for Subsequent Offering

Investor News 2025-01-09
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, […]
Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9

  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calendar

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories